Liver Disease
From the Journals
NAFLD vs. MAFLD: What’s in a name?
NAFLD may not be the most appropriate name because “nonalcoholic” may overemphasize the absence of alcohol, but is “metabolic associated” any...
Feature
DOJ complaint flags HCV drug denials for people with addiction
Alabama Medicaid has an illegal policy of denying HCV treatment to people who have used illegal drugs or alcohol, according to the complaint.
From the Journals
PPIs should be used ‘judiciously’ in patients with cirrhosis
“Experts call for “nuanced” prescribing of proton pump inhibitors to patients with cirrhosis in study that found lower mortality only in those...
Commentary
Alarming global rise in pediatric hepatitis: Expert Q&A
For pediatricians, an awareness of the “outbreak” may allow the clinician to extend the typical workup of a child presenting with an undefined,...
From the Journals
Newly defined liver disorder associated with COVID mortality
From the Journals
To engage injection drug users in HCV care, go to where they are
From the Journals
Less cirrhosis but worse outcomes for Black patients with NASH
Black people with nonalcoholic steatohepatitis are more likely to die in the hospital, even though they are less likely to have cirrhosis.
From the AGA Journals
Locoregional therapy lowers wait-list dropout in HCC
Bridging strategies with locoregional therapy are recommended for liver transplant candidates who have to wait 6 months or longer for transplant...
News from the FDA/CDC
CDC recommends hep B vaccination for most adults
The CDC said it wants to expand vaccinations because, after decades of progress, the number of new hepatitis B infections is increasing among...
From the AGA Journals
New HBV model may open door to more effective antivirals
The researchers hope this novel model will provide a unique platform for studying HBV cccDNA that could lead to HBV cure.